13C-Metabolic Flux Analysis of Central Carbon Metabolism Using GC-MS

Importance of the Topic

Understanding intracellular metabolic fluxes is critical for unraveling cellular physiology in biotechnology, medicine and pharmacology. 13C-metabolic flux analysis provides direct insights into pathway activities, branch ratios and reaction directions that cannot be inferred reliably from metabolome, transcriptome or proteome alone. This approach enables characterization of microbial production strains, identification of cancer-specific metabolic alterations, and optimization of biochemical processes for valuable chemicals.

Objectives and Study Overview

This technical report presents a detailed protocol for performing 13C-metabolic flux analysis of central carbon metabolism in Escherichia coli using GC-MS and HPLC. Key goals include quantifying flux split between glycolysis and the pentose phosphate pathway, determining TCA cycle directionality, identifying inactive pathways (glyoxylate shunt, Entner–Doudoroff), and demonstrating software-driven flux estimation workflows.

Methodology and Instrumentation

Escherichia coli MG1655 was cultured in M9 minimal medium with a 1:1 mixture of [1-13C] and [U-13C] glucose. Time-course sampling allowed measurement of optical density, extracellular glucose and acetate by HPLC, and 13C labeling of proteinogenic amino acids by GC-MS.

• Cell washing and pelleting: saline washes and centrifugation at 10,000 rpm, 4 °C.
• Protein hydrolysis: 6 N HCl, sealed ampoules at 105 °C for 18 h.
• Derivatization: t-butyldimethylsilyl (tBDMS) of amino acids with MTBSTFA+1% TBDMCS at 95 °C for 1 h.
• GC-MS conditions: Shimadzu GCMS-TQ8040, DB-5MS+DG column, SIM mode with Smart SIM optimization, ion source 200 °C, interface 250 °C.
• HPLC conditions: Shimadzu Prominence with RID-20A, Aminex HPX-87H column, 1.5 mM H2SO4, 65 °C.
• Data integration: OpenMebius software for model building, natural isotope correction, and flux fitting.

Key Results and Discussion

Integration of GC-MS labeling and HPLC uptake/secretion rates revealed that 75% of glucose entered glycolysis and 23% flowed through the oxidative pentose phosphate pathway. The TCA cycle operated predominantly in the forward oxidative direction, while glyoxylate shunt and Entner–Doudoroff pathway exhibited negligible flux. Acetate excretion was confirmed in mid-log phase cultures. These results demonstrate robust determination of branch ratios, cycle directionality and inactive routes under aerobic growth.

Benefits and Practical Applications

• Quantifies in vivo reaction rates for metabolic engineering of microbial cell factories.
• Identifies pathway bottlenecks and inactive routes to guide strain optimization.
• Enables assessment of disease-related flux changes in mammalian cells.
• Supports development of precision fermentation processes for high-value chemicals.

Future Trends and Potential Uses

Advances in ultra-fast sampling, multi-omic integration and isotopic non-stationary flux analysis will expand the scope of 13C-MFA. Automated method creation, high-throughput GC-MS/MS platforms and machine learning-driven model refinement promise more accurate flux maps in complex systems, including co-cultures and mammalian bioprocesses. Integration with single-cell technologies will enable flux profiling at unprecedented resolution.

Conclusion

This report outlines a comprehensive workflow for 13C-metabolic flux analysis of E. coli central carbon metabolism, combining precise sample preparation, advanced GC-MS and HPLC assays, and computational flux estimation. The methodology delivers quantitative insights into pathway utilization, cycle direction and inactive reactions, providing a powerful tool for fundamental biology and industrial biotechnology applications.

Reference

1. Metallo CM, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 481(7381):380–384 (2012).
2. Okahashi N, et al. Metabolic characterization of cultured mammalian cells by mass balance analysis, tracer labeling experiments and computer-aided simulations. J Biosci Bioeng. 120(6):725–731 (2015).
3. Toya Y, Shimizu H. Flux analysis and metabolomics for systematic metabolic engineering of microorganisms. Biotechnol Adv. 31(6):818–826 (2013).
4. Kajihata S, et al. OpenMebius: An Open Source Software for Isotopically Nonstationary 13C-Based Metabolic Flux Analysis. Biomed Res Int. 2014:627014 (2014).
5. Zamboni N, et al. 13C-based metabolic flux analysis. Nat Protoc. 4(6):878–892 (2009).
6. Ingraham JL, et al. Growth of the Bacterial Cell. Sinauer Associates, Sunderland, MA, USA, p.128 (1983).